Facebook post by University of Helsinki

Researchers have discovered a solution for improving the efficacy of oncolytic viruses used in cancer treatment. Researchers are able to envelop oncolytic viruses with the patient’s own cancer peptides, enabling tailored targeted treatment. The activation of the human immune response against cancer cells becomes significantly more effective.
Cancer vaccine platform a potential tool for targeted cancer therapy helsinki.fi

The method enables personally tailored targeted treatment.